Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH sec...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93b96fa396814dabb356853deba43638 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:93b96fa396814dabb356853deba43638 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:93b96fa396814dabb356853deba436382021-11-11T17:18:29ZCongestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension10.3390/ijms2221118911422-00671661-6596https://doaj.org/article/93b96fa396814dabb356853deba436382021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11891https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH secondary to right ventricular hypertrophy (RVH) related to monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH). Fifty male Wistar rats were divided into four groups and randomly assigned to control and experimental groups. Three experimental groups were submitted to intraperitoneal MCT inoculation (60 mg/kg) and were under its effect for 15, 30 and 37 days. The animals were then sacrificed, obtaining cardiac and hepatic tissues for anatomopathological and morphometric analysis. At macroscopic examination, the livers in the MCT groups presented a nutmeg-like appearance. PAH produced marked RVH and dilatation in the MCT groups, characterized by a significant increase in right ventricular free wall thickness (RVFWT) and chamber area. At histological evaluation, centrilobular congestion was the earliest manifestation, with preservation of the hepatocytes. Centrilobular hemorrhagic necrosis was observed in the groups exposed to prolonged MCT. Sinusoidal dilatation was markedly increased in the MCT groups, quantified by the Sinusoidal Lumen Ratio (SLR). The Congestive Hepatic Fibrosis Score and the Centrilobular Fibrosis Ratio (CFR) were also significantly increased in the MCT<sub>30</sub> group. Hepatic atrophy, steatosis, apoptotic bodies and, rarely, hydropic swelling were also observed. SLR correlated strongly with CFR and RVFWT, and CFR correlated moderately with RVFWT. Our rat model was able to cause CH, related to monocrotaline-induced PAH and RVH; it was feasible, reproducible, and safe.Douglas Mesadri GewehrAllan Fernando GiovaniniBeatriz Alvarez MattarAnelyse Pulner AgulhamAndressa de Souza BertoldiSeigo NagashimaFernando Bermudez KubruslyLuiz Fernando KubruslyMDPI AGarticleliver diseasecongestive hepatopathyhypertrophyright ventricularpulmonary arterial hypertensionmonocrotalineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11891, p 11891 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
liver disease congestive hepatopathy hypertrophy right ventricular pulmonary arterial hypertension monocrotaline Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
liver disease congestive hepatopathy hypertrophy right ventricular pulmonary arterial hypertension monocrotaline Biology (General) QH301-705.5 Chemistry QD1-999 Douglas Mesadri Gewehr Allan Fernando Giovanini Beatriz Alvarez Mattar Anelyse Pulner Agulham Andressa de Souza Bertoldi Seigo Nagashima Fernando Bermudez Kubrusly Luiz Fernando Kubrusly Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
description |
Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH secondary to right ventricular hypertrophy (RVH) related to monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH). Fifty male Wistar rats were divided into four groups and randomly assigned to control and experimental groups. Three experimental groups were submitted to intraperitoneal MCT inoculation (60 mg/kg) and were under its effect for 15, 30 and 37 days. The animals were then sacrificed, obtaining cardiac and hepatic tissues for anatomopathological and morphometric analysis. At macroscopic examination, the livers in the MCT groups presented a nutmeg-like appearance. PAH produced marked RVH and dilatation in the MCT groups, characterized by a significant increase in right ventricular free wall thickness (RVFWT) and chamber area. At histological evaluation, centrilobular congestion was the earliest manifestation, with preservation of the hepatocytes. Centrilobular hemorrhagic necrosis was observed in the groups exposed to prolonged MCT. Sinusoidal dilatation was markedly increased in the MCT groups, quantified by the Sinusoidal Lumen Ratio (SLR). The Congestive Hepatic Fibrosis Score and the Centrilobular Fibrosis Ratio (CFR) were also significantly increased in the MCT<sub>30</sub> group. Hepatic atrophy, steatosis, apoptotic bodies and, rarely, hydropic swelling were also observed. SLR correlated strongly with CFR and RVFWT, and CFR correlated moderately with RVFWT. Our rat model was able to cause CH, related to monocrotaline-induced PAH and RVH; it was feasible, reproducible, and safe. |
format |
article |
author |
Douglas Mesadri Gewehr Allan Fernando Giovanini Beatriz Alvarez Mattar Anelyse Pulner Agulham Andressa de Souza Bertoldi Seigo Nagashima Fernando Bermudez Kubrusly Luiz Fernando Kubrusly |
author_facet |
Douglas Mesadri Gewehr Allan Fernando Giovanini Beatriz Alvarez Mattar Anelyse Pulner Agulham Andressa de Souza Bertoldi Seigo Nagashima Fernando Bermudez Kubrusly Luiz Fernando Kubrusly |
author_sort |
Douglas Mesadri Gewehr |
title |
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
title_short |
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
title_full |
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
title_fullStr |
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
title_full_unstemmed |
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension |
title_sort |
congestive hepatopathy secondary to right ventricular hypertrophy related to monocrotaline-induced pulmonary arterial hypertension |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/93b96fa396814dabb356853deba43638 |
work_keys_str_mv |
AT douglasmesadrigewehr congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT allanfernandogiovanini congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT beatrizalvarezmattar congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT anelysepulneragulham congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT andressadesouzabertoldi congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT seigonagashima congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT fernandobermudezkubrusly congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension AT luizfernandokubrusly congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension |
_version_ |
1718432132516282368 |